Oncogenic osteomalacia.
Rapoport
J
J
Department of Nephrology and Hypertension, Kaplan Medical Center, Rehovot, Israel. jar@netvision.net.il
D000230:Adenocarcinoma / Q000150:complications* / Q000175:diagnosis / Q000556:secondary*; D000368:Aged; D001859:Bone Neoplasms / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000556:secondary*; D002762:Cholecalciferol / Q000008:administration & dosage; D018450:Disease Progression; D017809:Fatal Outcome; D005485:Flutamide / Q000627:therapeutic use; D006801:Humans; D008297:Male; D010018:Osteomalacia / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000209:etiology*; D010710:Phosphates / Q000008:administration & dosage; D017680:Potassium Compounds / Q000008:administration & dosage; D017430:Prostate-Specific Antigen / Q000032:analysis; D011471:Prostatic Neoplasms / Q000150:complications* / Q000175:diagnosis / Q000473:pathology*; D014057:Tomography, X-Ray Computed
D010710:Phosphates; D017680:Potassium Compounds; D002762:Cholecalciferol; D005485:Flutamide; C013216:potassium phosphate; D017430:Prostate-Specific Antigen; C018279:sodium phosphate